15 Dec 2022
Essential drugs that every interventionalist needs to know
Anchorperson:
H. Amin
Summary
In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.
Learning Objectives
- To review the beneficial cardiovascular effects of SGLT2 blockers and GLP RAs
- To find out more about the role of PCSK9 inhibitors in decreasing CV events
- To summarize the new role of P2 Y12 inhibitors as single anti-platelet agents post PCI